ovarian%20mass
OVARIAN MASS
Ovarian cysts are typically noted after clinical screening, or as a result of exam for a suspected pelvic mass, or an incidental finding in investigations done for other reasons.
Most ovarian masses manifest with few or mild nonspecific symptoms.
Ovarian masses in women of reproductive age are mostly benign but the risk of malignancy increases with age.
Ovarian cysts in the prepubertal patients especially after the first week of life are abnormal and likely to be neoplastic. In adolescent patients, majority of ovarian masses are functional cysts.
  1. Drake J. Diagnosis and management of the adnexal mass. Am Fam Physician. 1998 May;57(10):2471-2476. PMID: 9614415
  2. Barney SP, Muller CY, Bradshaw KD. Pelvic masses. Med Clin North Am. 2008 Sep;92(5):1143-1161. http://www.ncbi.nlm.nih.gov/pubmed/?term=18721656. PMID: 18721656
  3. MacKenna A, Fabres C, Alam V, et al. Clinical Management of Functional ovarian cysts: a prospective and randomized study. Hum Reprod. 2000 Dec;15(12):2567-2569. PMID: 11098028
  4. Mahdavi A, Berker B, Nezhat C, et al. Laparoscopic management of ovarian cysts. Obstet Gynecol Clin North Am. 2004 Sep;31(3):581-592, ix. PMID: 15450319
  5. Zanetta G, Lissoni A, Torri V, et al. Role of puncture and aspiration in expectant management of simple ovarian cysts: a randomised study. BMJ. 1996 Nov;313(7065):1110-1113. PMID: 8916695
  6. Salat-Baroux J, Kutten F. Management of ovarian cysts. BMJ. 1996;313(7065):1098. http://www.ncbi.nlm.nih.gov/pubmed/?term=8916689. PMID: 8916689
  7. Mishell D, Stenchever M, Droegemuller W, Herbst A. Benign gynecologic lesions. In: Stenchever M. Comprehensive Gynecology. 4th ed. St. Louis: Mosby; 2001
  8. Mishell D, Stenchever M, Droegemueller W, Herbst A. Differential diagnosis of major gynecologic problems by age groups: vaginal bleeding, pelvic pain, pelvic mass. In: Stenchever M. Comprehensive Gynecology. 4th ed. St. Louis: Mosby; 2001.
  9. Benign diseases of the female reproductive tract. In: Berek JS, Adashi EY, Hillard PA. Novak's gynecology. 12th. Baltimore, MD: Lippincott Williams & Wilkins; 1996:361-77.
  10. MedWormhttp://www.medworm.com/rss/index.php/OBGYN/29/http://www.medworm.com/rss/medicalfeeds/specialities/OBGYN.xml
  11. MedWormhttp://www.medworm.com/rss/index.php/Cancer-%26-Oncology/6/http://www.medworm.com/rss/medicalfeeds/specialities/Cancer-Oncology.xml
  12. Ovarian cysts. Best Practice. http://bestpractice.bmj.com. Sep 2012. Accessed 17 Jul 2013.
  13. Graham L. ACOG releases guidelines on the management of adnexal masses. American College of Obstetricians and Gynecologists. http://www.greenjournal.org. Jul 2007. Accessed 25 Feb 2010.
  14. Valesky WW, Silverberg MA. Ovarian cysts. eMedicine. http://emedicine.medscape.com. Aug 2009. Accessed 25 Feb 2010.
  15. Royal College of Obstetricians and Gynaecologists. Ovarian cysts in postmenopausal women. http://www.rcog.org.uk. 2003.
  16. Royal College of Obstetricians and Gynaecologists (RCOG), British Society of Gynaecological Endoscopy. Management of suspected ovarian masses in premenopausal women (Green-top guideline no. 62). RCOG. http://www.rcog.org.uk. Nov 2011.
  17. Yeoh M. Investigation and management of an ovarian mass. Aust Fam Physician. 2015;44(1):48-52. http://www.racgp.org.au. PMID: 25688960
  18. Royal College of Obstetricians & Gynaecologists. The management of ovarian cysts in postmenopausal women. Green-top guideline no. 34. RCOG. https://www.rcog.org.uk. Jul 2016. Accessed 18 Oct 2016.
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
In patients with type 2 diabetes, obesity may be protective against vision-threatening diabetic retinopathy, a recent Korea study has shown.
Yesterday
The aromatase inhibitor anastrozole shows promise in the treatment of children with congenital adrenal hyperplasia, reducing bone age advancement without adversely affecting bone mineral density and visceral adipose tissue, as shown in a recent study.
Roshini Claire Anthony, 5 days ago

Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.

6 days ago
The use of opioids may have limited long-term efficacy in the management of chronic noncancer pain, reports a new study.